More News

15 Jul 2021 Lilly Announces Acquisition of Protomer Technologies
13 Jul 2021 ExCellThera and Astellas enter into a license for the use of molecule UM171 in the field of pluripotent stem cells
13 Jul 2021 eTheRNA immunotherapies and Ghent University Announce mRNA Delivery Collaboration and License Agreement
13 Jul 2021 48Hour Discovery and RayzeBio Announce Strategic Research Collaboration to Discover & Develop Novel Peptide-Based Radiopharmaceuticals
13 Jul 2021 Ionis enters exclusive licensing agreement with Bicycle Therapeutics aimed at further advancing LICA technology
13 Jul 2021 Biogen and Innocare Announce License and Collaboration Agreement For Orelabrutinib, an Innovative CNS Penetrant BTK Inhibitor For the Potential Treatment of Multiple Sclerosis
13 Jul 2021 Servier and Nymirum Announce Strategic Collaboration to Discover and Develop RNA-Targeted Small Molecule Therapeutics
13 Jul 2021 Prothena and Novo Nordisk announce acquisition agreement for Prothena’s ATTR amyloidosis programme
09 Jul 2021 I-Mab Expands Emerging Portfolio of Next Generation Novel Oncology Therapeutics Through Cutting-Edge mRNA and AI Technology Platforms
09 Jul 2021 Vor Biopharma Announces Collaboration with Janssen to Develop Engineered Hematopoietic Stem Cell Transplants Combined With a Bi-Specific Antibody Therapy for Acute Myeloid Leukemia (AML)
09 Jul 2021 Verge Genomics Announces Three-Year Collaboration With Lilly to Discover and Develop Novel Treatments Using Its AI-Driven All-in-Human Platform
09 Jul 2021 F-star Therapeutics Enters into Exclusive Licensing Agreement with AstraZeneca for Novel STING Inhibitors
06 Jul 2021 Eureka Therapeutics Announces New GPRC5D License Agreement with Sanofi to Target Multiple Myeloma
06 Jul 2021 South-Korean biotech Y-Biologics and French mid-pharma Pierre Fabre enter into a worldwide exclusive license agreement in the highly innovative field of immuno-oncology
06 Jul 2021 Sosei Heptares and InveniAI Enter a Multi-target AI-powered and GPCR-focused Drug Discovery Collaboration
02 Jul 2021 Spero Therapeutics Announces $40 Million Equity Investment from Pfizer Inc. and Licensing Agreement for SPR206
02 Jul 2021 Seres Therapeutics, Nestlé Health Science Announce SER-109 Co-Commercialization License Agreement
01 Jul 2021 Sensei Biotherapeutics Announces Prioritization of Next-Generation Multi-Antigenic ImmunoPhage Platform, Monoclonal Antibody and Nanobody Programs
01 Jul 2021 Orchard Therapeutics and Pharming Group Announce Collaboration to Develop and Commercialize ex vivo autologous HSC Gene Therapy for Hereditary Angioedema
29 Jun 2021 Ixaka and SomaLogic enter research collaboration to develop bispecific agents for oncology
29 Jun 2021 Synaffix Licenses its Award-Winning ADC Technology in Deal Adding a New ADC to Innovent’s Pipeline
24 Jun 2021 Nanoscope Therapeutics Announces FDA Approval of IND for Phase 2b clinical trial of Optogenetic Gene Monotherapy to Restore Vision in Patients with Retinitis Pigmentosa
24 Jun 2021 eTheRNA and VUB expand strategic collaboration to engineer next generation mRNA therapeutics with TetraMix®
23 Jun 2021 uniQure to Acquire Corlieve Therapeutics and Advance its Gene Therapy Program to Treat Temporal Lobe Epilepsy (TLE)
22 Jun 2021 ViiV Healthcare and Halozyme enter global collaboration and license agreement for ENHANZE® drug delivery technology to enable development of "ultra-long-acting" medicines for HIV

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2021 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up